FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.

Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

Pumpkin, sweet potatoes, and carrots are among the foods highest in beta-carotene, a powerful antioxidant the body converts ...

Sheldon Ekirch spends a lot of time on hold with her health insurance company. Sometimes, as the minutes tick by and her frustration mounts, Ekirch, 30, opens a meditation app on her phone. Patients ...